Wanbury Ltd has expanded its international business opportunities by filing a Drug Master File (DMF) in South Africa for Tramadol HCl API. The company has also filed DMFs in the Philippines and Singapore for Metformin HCl API to meet customer requirements.

Wanbury has added additional Key Starting Material (KSM) vendors to strengthen supply-chain continuity for its CEP-filed Paroxetine HCl API and has received approval from the European Directorate for the Quality of Medicines and Healthcare (EDQM).

Additionally, the Therapeutic Goods Administration (TGA) has accepted Wanbury’s compliance report addressing inspection observations, enabling the company to continue supplying its APIs to the Australian market.